secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocean Biomedical, Inc. (OCEA)
CIK:        0001869974
Form:       8-K
Filed at:   2025-01-15T23:59:59+00:00
Accession:  0001493152-25-002237
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocean Biomedical receives Nasdaq delisting notice for failure to hold annual meeting
--------------------------------------------------------------------------------

- Nasdaq notified Ocean Biomedical on Jan 7, 2025, that it failed to hold an annual meeting within 12 months of FY2023 end, violating Rule 5620(a).
- This deficiency serves as an additional basis for delisting; the Nasdaq Hearings Panel will consider it in the ongoing listing review.
- Company must submit views by Jan 14, 2025, and plans to hold annual meeting no later than March 31, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1869974/000149315225002237/0001493152-25-002237-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1869974/000149315225002237/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-002237

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer